Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Phase I and pharmacologic study of a 3-hour infusion of paclitaxel followed by cisplatinum and 5-fluorouracil in patients with advanced solid tumors.

Bhalla KN, Kumar GN, Walle UK, Ibrado AM, Javed T, Stuart RK, Reed C, Arbuck SG, Walle T.

Clin Cancer Res. 1999 Jul;5(7):1723-30.

3.
5.

Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked.

Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP, Wang X.

Science. 1997 Feb 21;275(5303):1129-32.

6.

Co-expression of several molecular mechanisms of multidrug resistance and their significance for paclitaxel cytotoxicity in human AML HL-60 cells.

Huang Y, Ibrado AM, Reed JC, Bullock G, Ray S, Tang C, Bhalla K.

Leukemia. 1997 Feb;11(2):253-7.

PMID:
9009089
7.

Estrogen increases intracellular p26Bcl-2 to p21Bax ratios and inhibits taxol-induced apoptosis of human breast cancer MCF-7 cells.

Huang Y, Ray S, Reed JC, Ibrado AM, Tang C, Nawabi A, Bhalla K.

Breast Cancer Res Treat. 1997 Jan;42(1):73-81.

PMID:
9116321
9.

Intracellular metabolism of Ara-C and resulting DNA fragmentation and apoptosis of human AML HL-60 cells possessing disparate levels of Bcl-2 protein.

Bullock G, Ray S, Reed JC, Krajewski S, Ibrado AM, Huang Y, Bhalla K.

Leukemia. 1996 Nov;10(11):1731-40.

PMID:
8892676
10.
11.

Bcl-xL overexpression inhibits taxol-induced Yama protease activity and apoptosis.

Ibrado AM, Huang Y, Fang G, Bhalla K.

Cell Growth Differ. 1996 Aug;7(8):1087-94.

12.

Effects of modulators of protein kinases on taxol-induced apoptosis of human leukemic cells possessing disparate levels of p26BCL-2 protein.

Ponnathpur V, Ibrado AM, Reed JC, Ray S, Huang Y, Self S, Bullock G, Nawabi A, Bhalla K.

Clin Cancer Res. 1995 Nov;1(11):1399-406.

13.

pIXY321 protects against Ara-C or taxol-induced apoptosis and loss of clonogenic survival of normal human bone marrow progenitor cells.

Bhalla K, Ibrado AM, Bradt JE, Ray S, Huang Y, Tang C, Nawabi A, Hoffman R.

Leukemia. 1995 Nov;9(11):1851-6.

PMID:
7475274
14.

Combined antileukemic activity of pIXY 321 and Ara-C against human acute myeloid leukemia cells.

Tang C, Huang Y, Ponnathpur VS, Ray S, Mahoney ME, Bullock G, Ibrado AM, Bhalla K.

Leuk Lymphoma. 1994 Nov;15(5-6):445-51.

PMID:
7874002
15.

Characterization of a human myeloid leukemia cell line highly resistant to taxol.

Bhalla K, Huang Y, Tang C, Self S, Ray S, Mahoney ME, Ponnathpur V, Tourkina E, Ibrado AM, Bullock G, et al.

Leukemia. 1994 Mar;8(3):465-75.

PMID:
7907395
16.

1-beta-D-arabinofuranosylcytosine-, mitoxantrone-, and paclitaxel-induced apoptosis in HL-60 cells: improved method for detection of internucleosomal DNA fragmentation.

Ray S, Ponnathpur V, Huang Y, Tang C, Mahoney ME, Ibrado AM, Bullock G, Bhalla K.

Cancer Chemother Pharmacol. 1994;34(5):365-71.

PMID:
7915211
17.

Effect of combined treatment with interleukin-3 and interleukin-6 on 4-hydroperoxycyclo-phosphamide-induced programmed cell death or apoptosis in human myeloid leukemia cells.

Bullock G, Tang C, Tourkina E, Ibrado AM, Lutzky J, Huang Y, Mahoney ME, Bhalla K.

Exp Hematol. 1993 Dec;21(13):1640-7.

PMID:
8243566
18.

High-dose mitoxantrone induces programmed cell death or apoptosis in human myeloid leukemia cells.

Bhalla K, Ibrado AM, Tourkina E, Tang C, Grant S, Bullock G, Huang Y, Ponnathpur V, Mahoney ME.

Blood. 1993 Nov 15;82(10):3133-40.

19.

Taxol induces internucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells.

Bhalla K, Ibrado AM, Tourkina E, Tang C, Mahoney ME, Huang Y.

Leukemia. 1993 Apr;7(4):563-8.

PMID:
8096557
20.

Effect of hemopoietic growth factors G-CSF and pIXY 321 on the activity of high dose Ara-C in human myeloid leukemia cells.

Bhalla K, Tourkina E, Huang Y, Tang C, Mahoney ME, Ibrado AM.

Leuk Lymphoma. 1993;10 Suppl:123-31.

PMID:
7683227
21.
23.
24.

Supplemental Content

Loading ...
Support Center